APL’s Building 201 was recognized as runner-up for Lab of the Year by the Scientific Equipment and Furniture Association, ...

Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead asset, nizubaglustat, will feature ...